|
CBR4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.87738713464114E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.07651690181865E-12 |
| Normal-vs-Stage2 |
9.839300E-04 |
| Normal-vs-Stage3 |
2.95430346852754E-13 |
| Normal-vs-Stage4 |
1.00940000802296E-09 |
| Stage1-vs-Stage2 |
6.293800E-01 |
| Stage1-vs-Stage3 |
9.972700E-04 |
| Stage1-vs-Stage4 |
1.424290E-02 |
| Stage2-vs-Stage3 |
1.659760E-02 |
| Stage2-vs-Stage4 |
5.701500E-02 |
| Stage3-vs-Stage4 |
7.756400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.75137682134618E-12 |
| Normal-vs-AfricanAmerican |
7.35440042198832E-10 |
| Normal-vs-Asian |
2.09099999981532E-07 |
| Caucasian-vs-AfricanAmerican |
6.500600E-01 |
| Caucasian-vs-Asian |
2.419800E-01 |
| AfricanAmerican-vs-Asian |
2.458800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.647881913731E-13 |
| Normal-vs-Female |
5.29387644832013E-12 |
| Male-vs-Female |
5.660400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.68665081901054E-12 |
| Normal-vs-Extreme_Weight |
2.71338507218388E-13 |
| Normal-vs-Obese |
1.25820465157744E-11 |
| Normal-vs-Extreme_Obese |
9.148100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.553400E-01 |
| Normal_Weight-vs-Obese |
3.634200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.975890E-03 |
| Extreme_Weight-vs-Obese |
8.800000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.152400E-02 |
| Obese-vs-Extreme_Obese |
3.829600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.980900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.32139854613911E-11 |
| Normal-vs-Age(61-80Yrs) |
4.9960036108132E-14 |
| Normal-vs-Age(81-100Yrs) |
1.9942003604001E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.336610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.494800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.129800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.208200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.948100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.609810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.80949724490642E-11 |
| Normal-VS-Type2 PRCC |
1.62470037423645E-12 |
| Normal-VS-KIRP CIMP |
1.66300306858602E-12 |
| Normal-VS-Unclassified PRCC |
2.37770000000026E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.42410000000404E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.46779999996316E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
8.908200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.58119999999729E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.360330E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.13079999997101E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.89714951818132E-12 |
| Normal-vs-N1 |
1.33226762955019E-15 |
| Normal-vs-N2 |
3.65950000302817E-08 |
| N0-vs-N1 |
5.217600E-03 |
| N0-vs-N2 |
7.163700E-02 |
| N1-vs-N2 |
5.679200E-01 |
|
|
